Tenofovir Disoproxil Fumarate in the Management of Chronic B Infection in Children

Creative Commons License

GÜMÜŞ E., Karhan A. N., Hizarcioglu-Gulsen H., DEMİR H., Temizel İ. N.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.27, sa.3, ss.142-147, 2021 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4274/vhd.galenos.2021.2020-11-2
  • Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.142-147
  • Anahtar Kelimeler: Antiviral, chronic hepatitis B infection, nucleos(t)ide analog, tenofovir disoproxil fumarate, CHRONIC HEPATITIS-B, LAMIVUDINE, ADOLESCENTS, CHILDHOOD, THERAPY, TRIAL
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objectives: The aim of this study was to present real-world data regarding the efficacy and safety of tenofovir disoproxil fumarate (TDF) in pediatric patients with chronic hepatitis B (CHB).